Literature DB >> 16418171

Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells.

Cora Weigert1, Anita M Hennige, Rainer Lehmann, Katrin Brodbeck, Frank Baumgartner, Myriam Schaüble, Hans U Häring, Erwin D Schleicher.   

Abstract

The exercise-induced interleukin (IL)-6 production and secretion within skeletal muscle fibers has raised the question of a putative tissue-specific function of IL-6 in the energy metabolism of the muscle during and after the exercise. In the present study, we followed the hypothesis that IL-6 signaling may directly interact with insulin receptor substrate (IRS)-1, a keystone in the insulin signaling cascade. We showed that IL-6 induces a rapid recruitment of IRS-1 to the IL-6 receptor complex in cultured skeletal muscle cells. Moreover, IL-6 induced a rapid and transient phosphorylation of Ser-318 of IRS-1 in muscle cells and in muscle tissue, but not in the liver of IL-6-treated mice, probably via the IL-6-induced co-recruitment of protein kinase C-delta. This Ser-318 phosphorylation improved insulin-stimulated Akt phosphorylation and glucose uptake in myotubes since transfection with an IRS-1/Glu-318 mutant simulating a permanent phospho-Ser-318 modification increased Akt phosphorylation and glucose uptake. Noteworthily, two inhibitory mechanisms of IL-6 on insulin action, phosphorylation of the inhibitory Ser-307 residue of IRS-1 and induction of SOCS-3 expression, were only found in liver but not in muscle of IL-6-treated mice. Thus, the data provided evidence for a possible molecular mechanism of the physiological metabolic effects of IL-6 in skeletal muscle, thereby exerting short term beneficial effects on insulin action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418171     DOI: 10.1074/jbc.M509782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

Review 2.  Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations.

Authors:  Christoph Hoffmann; Cora Weigert
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

3.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

Authors:  Helga Ellingsgaard; Irina Hauselmann; Beat Schuler; Abdella M Habib; Laurie L Baggio; Daniel T Meier; Elisabeth Eppler; Karim Bouzakri; Stephan Wueest; Yannick D Muller; Ann Maria Kruse Hansen; Manfred Reinecke; Daniel Konrad; Max Gassmann; Frank Reimann; Philippe A Halban; Jesper Gromada; Daniel J Drucker; Fiona M Gribble; Jan A Ehses; Marc Y Donath
Journal:  Nat Med       Date:  2011-10-30       Impact factor: 53.440

Review 4.  Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

Authors:  B Brooks-Worrell; J P Palmer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  Gestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring.

Authors:  Chellakkan S Blesson; Kunju Sathishkumar; Vijayakumar Chinnathambi; Chandrasekhar Yallampalli
Journal:  Endocrinology       Date:  2014-05-05       Impact factor: 4.736

6.  gp130 receptor ligands as potential therapeutic targets for obesity.

Authors:  Mark A Febbraio
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

7.  mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice.

Authors:  Stefan Thiem; Thomas P Pierce; Michelle Palmieri; Tracy L Putoczki; Michael Buchert; Adele Preaudet; Ryan O Farid; Chris Love; Bruno Catimel; Zhengdeng Lei; Steve Rozen; Veena Gopalakrishnan; Fred Schaper; Michael Hallek; Alex Boussioutas; Patrick Tan; Andrew Jarnicki; Matthias Ernst
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

8.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.

Authors:  Stephan Wueest; Reto A Rapold; Desiree M Schumann; Julia M Rytka; Anita Schildknecht; Ori Nov; Alexander V Chervonsky; Assaf Rudich; Eugen J Schoenle; Marc Y Donath; Daniel Konrad
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

9.  Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization.

Authors:  Meghan Kelly; Marie-Soleil Gauthier; Asish K Saha; Neil B Ruderman
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

Review 10.  The role of interleukins in insulin resistance and type 2 diabetes mellitus.

Authors:  Bruno Fève; Jean-Philippe Bastard
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.